Eibich P, et al. - The aim of this study was to present treatment pathways and associated costs of medication therapy for people with type 2 diabetes in the UK, their variability and changes over time. According to the data, medication therapy has undergone substantial changes during the period covered in this study. For example, therapy is initiated earlier and is less expensive than in the past. The data serve in this study will prove feasible for future modelling studies, e.g. of stratified treatment approaches.